Ferring Pharmaceuticals

ZOMACTON™

somatropin (rDNA origin) for injection, Growth hormone therapy indicated for treatment of growth failure in pediatric patients due to GHD, Turner syndrome, and other conditions.

Growth Hormone for Pediatric Growth Failure

ZOMACTON™ is a recombinant human growth hormone manufactured by Ferring Pharmaceuticals. It is indicated for the long-term treatment of pediatric patients with growth failure due to growth hormone deficiency, Turner syndrome, and short stature homeobox-containing gene deficiency.

  • Available in 5 mg and 10 mg vial formulations
  • Indicated for growth failure due to GHD in children
  • Also indicated for Turner syndrome and SHOX deficiency
  • Comprehensive patient/caregiver education materials
  • Enrollment form for patient support programs
Available Strengths
ZOMACTON™ 5 mg vial
ZOMACTON™ 10 mg vial

Patient & Clinical Resources

Back to Growth Disorders
Traveling with your medication? This medication requires refrigeration. Our partner 4AllFamily offers insulin coolers and medical travel cases to keep your medication safe wherever you go.
Shop Now

Questions About ZOMACTON™?

Our team is ready to help with enrollment, insurance coverage, and injection training resources.